Edit Pique

I read with interest your articles on peer review, especially "Pique and Critique" (The Scientist, July 11, 1988). Of course there are problems with anonymity in the peer-review system; authors are few who have not at some time in their careers felt real or perceived offense from a negative review. In the mathematical sciences, which I know the best, this is a recurring problem. Various measures have been proposed from time to time. Some years ago, for instance, one journal experimented by delet

Written byIvan Rival
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Of course there are problems with anonymity in the peer-review system; authors are few who have not at some time in their careers felt real or perceived offense from a negative review. In the mathematical sciences, which I know the best, this is a recurring problem. Various measures have been proposed from time to time. Some years ago, for instance, one journal experimented by deleting the authors' names from the submission copy sent to the referees. The experiment did not last long. As near as I can tell, all efforts to tamper with the long tradition of peer review and anonymity have failed.

There is, however, a remedy that your recent articles have overlooked and which seems to me to neatly solves the occasional frustration. A responsible editor can be expected to screen reports before sending them on to his authors. In most cases, a gentle editing of those few ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies